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Chicory roots are rich in inulin that is degraded into SCFA in the caecum and colon. Whole-body SCFA metabolism was investigated in rats during
food deprivation and postprandial states. After 22 h of food deprivation, sixteen rats received an IV injection of radioactive 14C-labelled SCFA.
The volume of distribution and the fractional clearance rate of SCFA were 0·25–0·27 litres/kg and 5·4–5·9 %/min, respectively. The half-life in the
first extracellular rapidly decaying compartment was between 0·9 and 1·4 min. After 22 h of food deprivation, another seventeen rats received a
primed continuous IV infusion of 13C-labelled SCFA for 2 h. Isotope enrichment (13C) of SCFA was determined in peripheral arterial blood by
MS. Peripheral acetate, propionate and butyrate turnover rates were 29, 4 and 0·3mmol/kg per min respectively. Following 4 weeks of treatment
with chicory root or control diets, eighteen fed rats received a primed continuous IV infusion of 13C-labelled SCFA for 2 h. Intestinal degradation
of dietary chicory lowered caecal pH, enhanced caecal and colonic weights, caecal SCFA concentrations and breath H2.The diet with chicory sup-
plementation enhanced peripheral acetate turnover by 25 % (P¼0·017) concomitant with an increase in plasma acetate concentration. There were
no changes in propionate or butyrate turnovers. In conclusion, by setting up a multi-tracer approach to simultaneously assess the turnovers of acet-
ate, propionate and butyrate it was demonstrated that a chronic chicory-rich diet significantly increases peripheral acetate turnover but not that of
propionate or butyrate in rats.
Short-chain fatty acids: Chicory: Kinetics: Rats
Dietary fibres are fermented in the large intestine of man by
anaerobic bacteria to produce SCFA, such as acetate, propio-
nate and butyrate, and some gases1,2. SCFA are found in large
quantities in portal vein blood after intestinal absorption and
to a lesser extent in peripheral blood. Acetate is the most pro-
minent SCFA in peripheral blood, it is favoured by most cells
of the body as an energetic substrate and its oxidation contrib-
utes to about 7 % whole-body resting energy expenditure in
man3. All SCFA contribute to gut health and maintenance2,4
and may provide further benefits for peripheral metabolism1.
The intestinal production of SCFA has been assessed in
vitro5, in in vivo animal models (pigs, dogs, rats)1 and also
in human subjects6. Most studies have been limited to the
determination of SCFA concentrations in biological fluids in
animals and human subjects and only a few have investigated
the peripheral turnover rate of acetate or of propionate3,7 – 9.
To our knowledge no studies have investigated the peripheral
turnover rates of propionate and butyrate after dietary fibre
ingestion in either animals or human subjects.
The production of SCFA in the intestine occurs at a rate that
depends upon the rate of entry of unabsorbed nutrients into the
intestine and bacterial activity within the gut. It varies from a
minimum during fasting, to a maximum several hours
after dietary fibre ingestion and is dose dependent. After
their production in, and absorption from, the gut SCFA are
transported to the liver, where they combine with those pro-
duced endogenously during substrate metabolism. To our
knowledge the endogenous production of propionate and buty-
rate is limited, but has not yet been evaluated. If it is possible
to differentiate intestinal SCFA from those that are endogen-
ously produced using labelling, one can estimate the intestinal
production rate of SCFA (Fig. 1) 10. The primary objective of
the present study was to develop an isotope-dilution technique
to determine whole-body SCFA turnover in a rat model. In a
first experiment we investigated the kinetics of acetate, pro-
pionate and butyrate in whole-body peripheral circulation
and in a second experiment we assessed their individual per-
ipheral turnover rates in rats deprived of food for 22 h. The
second objective was to quantify in a third experiment the
effect of 4-week chicory treatment on whole-body peripheral
SCFA turnover in rats.
Materials and methods
Animals and diets
The animal experiments were approved by the Cantonal
Committee for Ethics in Animal Experimentation (no. 1272;
*Corresponding author: Dr Etienne Pouteau, fax þ41 21 785 85 44, email etienne.pouteau@rdls.nestle.com
Abbreviations: FCR, fractional clearance rate; IV, intravenous; MPE, mole percent excess; MRT, mean residence time; MS, mass spectrometry; Ra, rate of
appearance; T11/2, half-life of first phase (rapid decay); T21/2, half-life of second phase (elimination decay); VD, volume of distribution.
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Service Ve´te´rinaire, Etat de Vaud, Lausanne, Switzerland).
Wistar rats were obtained from the Charles River Company
(L’Arbresle, France). [1-14C]acetate, Na salt (50mCi),
[1-14C]propionate, Na salt (250mCi) and [1-14C]butyrate, Na
salt (50mCi) were purchased from NENeLife Science Products,
Inc. (Boston, MA, USA). [1,2-13C2]acetate, [1-
13C]acetate,
[1-13C]propionate and [1-13C]butyrate Na salt tracers were pur-
chased from Cambridge Isotope Laboratories (Andover, MA,
USA). A conventional diet was used in experiments 1 and 2,
which contained 23·5 % protein, 5·5 % fat, 52 % carbohydrate
and 3 % fibre (Kliba 3310; Promivi Kliba SA, Kaiseraugst, Swit-
zerland). The diets in experiment 3 were the same conventional
diets enriched or not with 10 % chicory (chicory dry root; Friskies
SA, Amiens, France). The chicory was dry chicory roots com-
posed of 50–60 % inulin, a non-digestible fructo-oligosaccharide.
The chicory diet contained 8 % fibre. The metabolisable energy of
the diet was 14·0 kJ/g. The animals were adapted to the diet for at
least 1 week before all experiments.
Rat model. A rat model was developed for intravenous
(IV) tracer infusion and intra-arterial blood sample collection.
The rat was anaesthetised with isoflurane (Baxter AG, Volk-
etswil, Switzerland) for the duration of catheter insertion
and tracer kinetics. Particular attention was taken to gently
isolate the femoral vein and/or artery without injuring them.
For all experiments, a catheter (24G Insyte; Becton Dickinson
AG, Bale, Switzerland) was inserted into the femoral artery
for blood sampling. For experiments 2 and 3, a catheter
(24G Insyte) was also inserted into the femoral vein for
tracer infusions. A first blood sample (100–800ml) was
collected at time zero, in a heparinised tube, and was replaced
by injecting the same volume of sterile saline solution (0·9 %
NaCl). Regular blood sampling (800ml) was possible as the
sampling catheter was flushed with diluted heparin (10 % in
saline solution) after each sample collection. Particular atten-
tion was taken to maintain body temperature constant under
isoflurane anaesthesia. This rat model could be kept oper-
ational for 5 h. At the end of the kinetic measurements,
portal blood was eventually collected just before the rat was
killed by exsanguination.
Experiments
Experiment 1. The experiment had a parallel design. Sixteen
rats (eight males and eight females; weight 322·7 ^ 13·3 g)
were divided into three groups; one received the acetate
tracer injection (n 5), another the propionate injection (n 6)
and the other the butyrate injection (n 5). Rats that were
deprived of food for 22 h were submitted to kinetic studies in
which either radiolabelled acetate, propionate or butyrate tra-
cers were used (Fig. 1). The rats were anaesthetised, a catheter
was inserted into the femoral artery and a first blood sample
was taken at time zero (100ml). Each rat was injected with
either [1-14C]acetate (5·497 (SEM 0·088)mCi, 2·7483mmol),
[1-14C]propionate (6·407 (SEM 0·057)mCi, 0·1140mmol) or
[1-14C]butyrate (6·990 (SEM 0·007)mCi, 0·3548mmol) in a
randomised order. Arterial blood samples (100ml) were col-
lected every 30 s until 5 min, every 60 s until 10 min and at
12, 14, 16, 18, 20, 25 and 30 min. The rats were then killed.
The blood samples were analysed the same day.
Fig. 1. Principle of using isotope-labelled SCFA intravenous infusions to investigate intestinal fermentation from peripheral metabolism of SCFA. Bacterial fermen-
tation in the intestine produces SCFA that are transported through the liver to the peripheral blood circulation. The liver and whole body produce endogenous
SCFA. From the isotope-dilution principle, the isotope enrichments in arterial blood reflect the whole-body SCFA turnovers that were estimated in food-deprived
rats (Expts 1 and 2) and in the postprandial state (Expt 3 with control and chicory diets).
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Experiment 2. The experiment had a parallel design. Seven-
teen rats (adult males; 389·1 (SEM 8·4) g) were divided into three
groups; one received the acetate tracer infusion (n 6), another the
propionate infusion (n 5) and the other the butyrate infusion (n 6).
Stable isotopes of acetate, propionate or butyrate tracers were
used to determine their individual turnover rates in rats deprived
of food for 22 h (Fig. 1). The catheters were inserted under anaes-
thesia and a first arterial blood sample was collected at time zero
(800ml). Each rat received, intravenously, a primed continuous
infusion of either [1-13C]acetate (52·3 (SEM 2·1)mmol/kg and
0·98 (SEM 0·04)mmol/kg per min), [1-13C]propionate (48·0
(SEM 1·1)mmol/kg and 0·97 (SEM 0·02)mmol/kg per min) or
[1-13C]butyrate (49·7 (SEM 1·9)mmol/kg and 1·04 (SEM
0·05)mmol/kg per min) solubilised in 0.9 % NaCl sterile sol-
ution. Arterial blood samples (800ml) were collected at 60,
75, 90, 105 and 120 min. A final blood sample was collected
from the portal vein just before the rats were killed. All blood
samples were centrifuged (10 min at 1200 g) and plasma
stored at 2808C until analysis.
Experiment 3. The experiment had a parallel randomised
and controlled design. Eighteen rats (adult males; 378·2
(SEM 2·5 g) were randomly divided into two groups; one
received the chicory diet (chicory group; n 10) and the other
the conventional diet (control group; n 8) for 4 weeks and
stable-isotope kinetics were performed on the last day
(Fig. 1). Food was not restricted the night before the kinetic
studies. Each rat was fed by oral administration 1/12 of its
daily intake of either the conventional or the chicory diet
(according to their group assignment) every 30 min for 6 h
in order to mimic continuous feeding. In the remaining time,
each rat was placed in a 10 litre airtight transparent box for
12 min per h during the experiment to collect partially respired
air. After the last feeding by oral administration, the catheters
were inserted under anaesthesia and a first arterial blood
sample was collected (800ml). Each rat was then adminis-
tered, intravenously, a primed continuous infusion of
[1,2-13C2]acetate, [1-
13C]propionate and [1-13C]butyrate sim-
ultaneously (all tracers solubilised in 0·9 % NaCl sterile sol-
ution; 287 (SEM 5), 97 (SEM 2) and 49 (SEM 1)mmol/kg
priming doses and 2·84 (SEM 0·04), 0·96 (SEM 0·01) and
0·48 (SEM 0·01)mmol/kg per min infusion rates, respect-
ively). Arterial blood samples (800ml) were collected at 60,
75, 90, 105 and 120 min. A last blood sample was collected
from the portal vein before killing. Mucosa samples from
the caecum and the colon were obtained by scraping with a
glass slide. Caecal and colonic contents and respective muco-
sal and non-mucosal intestinal tissues were collected and
weighed. Intestinal contents and plasma were stored at
2808C until analysis.
Analysis
Radiolabelled tracers. Blood samples were prepared for
b þ radioactivity counting. Blood samples (100ml) were
centrifuged and 40ml plasma were pipetted into a scintil-
lation flask containing 20 ml scintillant (Ultima Gold, Pack-
ard Bioscience Comp., the Netherlands). A scintillation
counter (PerkinElmere, Regendorf, Switzerland) measured
and recorded b þ detection in counts per min. Data in
counts per min were transformed into dpm accounting for
quenching.
Stable isotope tracers. Measurements of [1,2-13C2]acetate,
[1-13C]acetate, [1-13C]propionate and [1-13C]butyrate enrich-
ments and SCFA concentrations in plasma were performed
as previously described11. Briefly, plasma samples (450ml)
were spiked with 10ml [2H3] acetate internal standard.
Samples were deproteinised with sulfosalicylic acid solution
(10ml, 1 g/litre; Fluka, Buchs, Switzerland) and centrifuged
at 2200 g for 10 min. The supernatant fraction was transferred
into a vial containing 10ml hydrochloric acid (10 M) (Panreac,
Barcelona, Spain), to which 3 ml diethyl ether (99·8 %; Fluka,
Buchs, Switzerland) were added. The vials were vortexed for
15 min and centrifuged for 10 min at 1200 g, then 8ml tert-
butyl-dimethyl-silyl-imidazole (Fluka Chemika, Buchs, Swit-
zerland) were added to the separated organic phase. The
sealed vials were heated to 608C for 30 min after which they
were cooled and evaporated to 200–300ml. Then 2ml were
injected into a gas chromatograph (model 5890A; Hewlett
Packard, Palo Alto, CA, USA) connected to a quadrupole
mass spectrometer (SSQ7000; Finnigan Mat, Bremen,
Germany). Chromatographic separations were carried out
with a 30 m £ 0·32 mm capillary column (DB5; J/W Scienti-
fic, Folsom, CA, USA) using the following temperature pro-
gramme: initial temperature at 408C for 1 min, then 708C/
min up to 608C, 108C/min up to 1108C and 708C/min up to
2508C for 1 min. Ammonia chemical ionisation and selected
ion monitoring were used on ions m/z 192, 193 and 194 for
acetate, m/z 206 and 207 for propionate and m/z 220 and
221 for butyrate for isotope enrichment determination.
Selected ion monitoring at m/z 195 was used for internal stan-
dard and concentration determination. Plasma concentrations
were expressed inmmol/l and isotope enrichments M0 þ 2
and M0 þ 1 in mole percent excess (MPE). Calibration
curves for plasma concentrations showed excellent linearity
from 1 to 1000mmol/l for acetate, propionate and butyrate.
Calibration curves for isotope enrichment (M0 þ 2 and
M0 þ 1) were linear from 0·5 to 99 MPE for [1,2-13C2]acetate,
[1-13C]acetate, [1-13C]propionate and [1-13C]butyrate11.
Caecal and colonic short-chain fatty acid analysis. SCFA
concentrations in caecum and colon contents were measured
using a method similar to that described earlier for plasma.
Samples of faeces (250 mg) were diluted in 1 ml aqueous sol-
ution (0·1 % HgCl2, 0·1 % H3PO4). The aqueous solution was
homogenised by vortexing (20 min) and centrifuging (5 min;
1200 g). Then 20ml hydrochloric acid (32 %) were added.
Part of the upper liquid layer (450ml) was then extracted
with diethyl ether (3 ml). Thereafter, the sample preparation
was identical to that described for plasma earlier. Analysis
was performed using the same chromatographic conditions
on another gas chromatograph–mass spectrometer (6890
Series; Hewlett Packard, Palo Alto, CA, USA) in electronic
ionisation mode with selected ion monitoring at m/z 117,
118, 119, 120 and 131, 132, 133, 134 and 145, 146, 147,
148 and 149 for labelled acetate, propionate and butyrate,
respectively11. SCFA concentrations in caecal contents were
expressed in mmol/g (g of whole caecal content).
Calculations
Radiolabelled tracers. Radiolabelled [14C]SCFA tracers were
injected and distributed into a first pool from which tracers were
rapidly eliminated into a second pool. A two-compartment
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modelling approach was used. The decay of [14C]SCFA tracers
(in dpm) as a function of time, y(t), during kinetics was fitted by a
bi-exponential curve using SigmaPlot (version 4.00) software12.
The equation of the fitting curve was:
yðtÞ ¼ A1 £ e2k1£ t þ A2 £ e2k2£ t
where A1 and A2 are constants (in dpm), and k1 and k2 are decay
constants (in per min).
The rapid decay from the first pool is defined by:
y1(t) ¼ A1 £ e 2k1£ t.
The elimination decay from the second pool is defined by:
y2(t) ¼ A2 £ e 2k2£ t.
The values A1, A2, k1 and k2 were determined using a non-
linear least-squares estimation. This procedure determines the
values that minimise the value for the residual sum of squares
(RSS), defined as:
RSS ¼
Xn
i¼1
zðtÞ2 yðtÞ 2
where z(t) are measured data at time t, y(t) is the value at time
t derived from the equation to fit the data from n number of
samples per kinetic.
Constants A1 and A2 were thereafter first transformed into
mCi, since it is known that 1 mCi equals 2·22 £ 106 dpm,
and further into mCi/l taking into account that 40ml plasma
were analysed. From this curve fitting, the following par-
ameters were calculated12:
The area under the curve (AUC in mCi £ min/l) of the
different [14C]SCFA tracer decays:
AUC10 ¼
A1
k1
þ A2
k2
where A1 and A2 are expressed in mCi/l, and k1 and k2 in per
min;
The volume of distribution (VD in litres/kg) of the different
SCFA, where SCFA are considered to be instantaneously and
homogeneously distributed:
VD ¼ dose
A1 þ A2 £
1
W
where dose is the radiolabelled tracer dose injected (in mCi),
and W is the rat weight in kg;
The fractional clearance rate (FCR in %/min) of the differ-
ent SCFA, the fractional rates at which SCFA are removed
from VD:
FCR ¼ 100 £ A1 þ A2
AUC10
The total clearance (C in ml/min) of the different SCFA from
VD:
Total C ¼ FCR £ VD £ W £ 1000;
The mean residence time (MRT in min) of the different
SCFA in VD:
MRT ¼
Ð1
0
t £ yðtÞdtÐ1
0
yðtÞdt
MRT ¼
A1
k 21
þ A2
k 22
A1
k1
þ A2
k2
The half-life of the first phase of the different SCFA, rapid
decay from the first compartment (T11/2) (in min):
T11=2 ¼ ln ð2Þ
k1
The half-life of the second phase of the different SCFA, elim-
ination decay from the second compartment (T21/2) (in min):
T21=2 ¼ ln ð2Þ
k2
Stable-isotope tracers. The [13C]SCFA tracers were con-
tinuously IV infused until an equilibrium was reached between
the tracers and the whole-body SCFA production. The plateau
values of isotope enrichment at steady state were equalled to
the mean isotope enrichments during the last 30 min tracer
infusion. Using the isotope-dilution principle13, the rates of
appearance or turnover (Ra in mmol/kg per min) of acetate,
propionate and butyrate were calculated using the steady-
state equation, as follows:
Ra ¼ i £ IEt
IEa
2 1
 
where i is the IV infusion rate (mmol/kg per min) of
[13C]SCFA tracers, IEt and IEa are the [
13C]SCFA isotope
enrichments of the tracer solution ([1,2-13C2]acetate,
[1-13C]acetate, [1-13C]propionate or [1-13C]butyrate) and of
arterial plasma at plateau, respectively, given in MPE.
The fractional extraction of the different SCFA by the intes-
tine (%extrac in %) was as follows:
%extrac ¼ 100 £ IEa £ Cað Þ2 IEpv £ Cpv
 
IEa £ Cað Þ
where Ca and Cpv are concentrations of SCFA, and IEa and
IEpv are isotope enrichments of [
13C]SCFA at plateau in the
femoral artery (a) and in the portal vein (pv), respectively.
The utilisation or uptake of acetate, propionate and butyrate
from intestinal tissues was evaluated assuming a blood flow
in the portal vein of 15 ml/min (in 300 g rats) according to
data from Jaeschke et al.14. Plasma flow was estimated
(assuming 45 % packed cell volume) to be 6·75 ml/min15, cal-
culated as follows:
Uptake ¼ %extrac £ Ca £ plasma flow
where ‘plasma flow’ is expressed in litres/kg per min and was
estimated from blood flow, packed cell volumes and rat body
weight. ‘Uptake’ is expressed in mmol/kg per min.
The production or release of acetate, propionate and buty-
rate from intestinal tissues was evaluated assuming a plasma
flow in the portal vein as above. The following calculation
E. Pouteau et al.290
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was performed:
Release ¼ uptake þ Cpv 2 Ca
  £ plasma flow
where plasma flow is expressed in litres/kg per min and
Release in mmol/kg per min.
Statistics
Statistics were performed using Statistica (version 5.1 G soft-
ware; StatSoft Ltd, London, UK). One-way ANOVA were
performed in experiment 1 between kinetic parameters of acet-
ate, propionate and butyrate groups. Kinetic parameters were
A1, A2, k1, k2, VD, FCR, total clearance, MRT, T11/2 and
T21/2. One-way ANOVA was used in experiment 2 to com-
pare parameters of the acetate, propionate and butyrate
groups followed by a Tukey honest significant difference
(HSD) test for unequal n per group. Paired t tests were per-
formed in experiment 3 to compare SCFA concentrations
between artery and portal vein and also to compare uptake
and release from intestinal tissues. Unpaired t tests were per-
formed in experiment 3 to compare outcomes after the chicory
diet treatment with those after the control diet. All data are
presented as mean values with their standard errors. Differ-
ences were considered to be statistically significant at P#0·05.
Results
Experiment 1: Kinetic parameters of plasma short-chain fatty
acids
The radiolabelled SCFA decays ([14C]acetate, [14C]propionate
and [14C]butyrate tracers) are shown in Fig. 2. Mean parameters
of bi-exponential decays (A1, A2, k1 and k2) and kinetic par-
ameters are presented in Table 1; no significant differences
were observed between acetate, propionate and butyrate. Distri-
bution volumes were not significantly different; similarly no
differences were observed for FCR, total clearance, MRT and
T21/2 between the SCFA. Rapid decay half-life (T11/2) was
not significantly shorter for acetate than for butyrate.
Experiment 2: Turnover of plasma short-chain fatty acids
The plasma isotope enrichments of [1-13C]acetate, [1-13C]pro-
pionate and [1-13C]butyrate reached a plateau during the last
30 min of each IV infusion (Fig. 3). Equal infusion rates of
[1-13C]acetate, [1-13C]propionate and [1-13C]butyrate
showed different plateau values of isotope enrichments at
3·5 (SEM 0·6), 22·0 (SEM 3·7) and 76·6 (SEM 3·6) MPE
(P,0·005), respectively. At the end of the IV infusions, no
labelled acetate enrichment was detected in the portal vein,
as opposed to labelled propionate (1·8 (SEM 0·6) MPE) and
butyrate (7·3 (SEM 5·6) MPE). The turnover rates of acetate,
propionate and butyrate in the whole-body peripheral circula-
tion were 29 (SEM 4), 4 (SEM 2) and 0·3 (SEM 0·1) mmol/kg per
min, respectively in 22 h food-deprived rats (with Raacetate .
Rapropionate . Rabutyrate; P,0·0001).
Experiment 3: Intestinal production of short-chain fatty acids
The body weights of the rats increased during both 4-week
diet treatments to 498 (SEM 8) g (þ32 %) and 495 (SEM 9)
g (þ31 %), with no difference between the control and chic-
ory diets, respectively. Food intake did not differ between
the diet treatments (24 (SEM 1) g/d). The arterial concen-
trations of acetate were higher after the chicory than the con-
trol diet treatment (P¼0·026), but no difference was observed
for propionate and butyrate (Table 2). The isotope enrichments
of [1,2-13C2]acetate, [1-
13C]propionate and [1-13C]butyrate
reached a plateau during the multi-tracer infusion (Fig. 4).
The plateau isotope enrichments in arterial blood of [1,2-13C2-
]acetate were lower after chicory than after the control treat-
ment (P¼0·025; Table 2). No difference was observed
between treatments in [1-13C]propionate isotope enrichment
Fig. 2. Decays of the tracer plasma level (common log scale) used for bi-
exponential curve fitting and kinetic parameter determination in adult rats that
received (A) a [1-14C]acetate, (B) a [1-14C]propionate or (C) a [1-14C]butyrate
intravenous injection (Expt 1). Data are means, with their standard errors
represented by vertical bars (n 5 for acetate and butyrate tracer groups; n 6
for propionate tracer group).
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in arterial and portal vein blood (Table 2). No difference was
observed in [1-13C]butyrate isotope enrichment in arterial
blood. Portal vein [1-13C]butyrate enrichment was lower
after chicory than after control diet treatment (P¼0·035;
Table 2). The Ra of acetate in the whole body was signifi-
cantly higher after the chicory-enriched than after the control
diet treatment (P¼0·017; Table 2). No difference was
observed in the Ra of propionate and butyrate between diet
treatments (Table 2). Intestinal extraction and rates of
uptake and release of acetate, propionate and butyrate were
not different between diet treatments (Table 3). The mean
pH in the caecal lumen was lower in the chicory group (5·7
(SEM 0·1)) compared with the control group (6·0 (SEM 0·1);
P¼0·017). Rats submitted to the chicory-enriched diet demon-
strated a significant increase in whole caecal and whole colo-
nic weights, as well as in empty caecal and empty colonic
weights compared with those on the control diet (P,0·01;
Fig. 5). The caecal content was also significantly higher
after the chicory diet, as well as non-mucosal colonic tissue
weight (P,0·05; Fig. 5). Concentrations of acetate, propio-
nate, iso-butyrate and iso-valerate were significantly increased
in the caecal content after 4-week-chicory treatment compared
with control treatment (Table 4), while concentrations of buty-
rate and valerate were not. The concentration of each SCFA
evolved differently in the colon compared with the more prox-
imal caecum; the colonic concentration of butyrate was
decreased after chicory treatment compared with control treat-
ment (Table 4). No methane was detected in expired breath in
any of the rats. The area under the curve (0–6 h) of breath H2
was significantly higher in rats that consumed the chicory diet
(176 (SEM 34) parts per million £ h) compared with the con-
trols (66 (SEM 6) parts per million £ h; P¼0·002).
Discussion
Dry chicory roots contain about 50–60 % inulin, which is a
non-digestible fructo-oligosaccharide. The intestinal fermenta-
tion of inulin produces exogenous SCFA that mix with those
produced endogenously16. We investigated the plasma kineticsT
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Fig. 3. [13C]isotope enrichments of acetate (X), propionate (W) and butyrate
(P) in arterial plasma during separate [1-13C]SCFA primed continuous IV
infusions in rats (Expt 2). Data are means, with their standard errors rep-
resented by vertical bars (n 6 for acetate and butyrate tracer groups; n 5 for
propionate tracer group). MPE, mole percent excess.
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and turnover rates of SCFA in food-deprived and fed rats
(Fig. 1). Interestingly the peripheral turnover rates of propio-
nate and butyrate were not negligible; however, a 4-week-
chicory diet did not enhance their turnovers. We observed
that a 4-week chicory diet increased intestinal fermentation
and was accompanied by a 25 % increase in peripheral acetate
turnover in rats.
Non-ruminant models have been used to study SCFA pro-
duction and metabolism1,17. Kien et al. evaluated butyrate
turnover in piglets that received a [13C]butyrate infusion into
the caecum17. While the rat model has been limited to the
determination of SCFA concentrations in blood and intestinal
contents19 – 21, in the present study, an isotope approach was
used to take into account the dynamics of SCFA metabolism.
The radioisotope-tracer experiment, in the present study, did
not reveal significant differences between SCFA kinetics in
rats. As a consequence, we used the same 2 h infusion rate
of different SCFA tracers to determine SCFA turnover rates
in experiment 2. It appeared, however, that the SCFA had sig-
nificantly different turnover rates when measured in the per-
ipheral circulation, since the stable-isotope dilution method
in experiment 2 is more accurate for turnover rate determi-
nations. Consequently the last experiment, experiment 3,
was conducted using adapted priming doses and infusion
rates of the different [13C]SCFA tracers, by proportionally
doubling the labelled acetate and lowering the labelled
butyrate priming doses and infusion rates. A concomitant
multi-tracer infusion technique was additionally developed
in experiment 3, which could be applicable in human subjects.
The study of SCFA plasma decays in experiment 1 revealed
unique data on the plasma kinetics of the different
SCFA. SCFA were rapidly cleared from the first pool (half-
life T11/2, 2 min), which represents the whole-body extra-
cellular volume, compared with the second, intracellular
pool, which cleared much more slowly (T21/2 ¼ 40–
65 min). No significant differences in any of the plasma kin-
etic parameters of SCFA were observed, probably because
their extracellular and intracellular distribution volumes are
similar. The distribution volumes of the SCFA are very similar
to those of glycerol22 and acetate in dogs (0·27 (SEM 0·16)
litres/kg)23. The turnover rate of acetate in the peripheral cir-
culation of 22 h food-deprived rats was three times higher than
that of human subjects in the post-absorptive state (8·4 (SEM
0·6) mmol/kg per min)3 and similar to that of 24 h food-
deprived dogs (24·4 (SEM 2·4) mmol/kg per min)23. The turn-
over of propionate in 22 h food-deprived rats was higher than
that (0·6mmol/kg per min) reported by Sbaı¨ et al.18 in metro-
nidazole-treated human patients with propionic acidaemia and
that (0·3mmol/kg per min) reported by Walter et al.9 in four
healthy human subjects. The use of different tracers and
different species can probably explain these discrepancies.
When the three experiments were compared, the following
logical ranking was observed, A1acetate , A1propionate ,
A1butyrate (NS) and k1acetate . k1propionate . k1butyrate (NS) in
experiment 1 (Table 1), in parallel with Raacetate .
Rapropionate . Rabutyrate (P,0·05) in experiments 2 and 3.
The ranking of the different SCFA turnover rates was identi-
cal, but not proportional, to their plasma concentrations and
is due to the fact that an increase in turnover rate is not necess-
arily accompanied by an increase in plasma concentration,
especially when the Ra and rate of disappearance of the
SCFA stays in equilibrium. This reinforces the relevance of
the turnover determination in our experiments.
In experiment 3, we observed a clear caeco-colonic fermenta-
tion of the non-digestible inulin component of the chicory diet.
The rats consuming the 4-week chicory diet demonstrated, as
expected24,25, a higher caecal and colonic weight, increased intes-
tinal hypertrophy, higher SCFA concentrations in the caecum, a
fall in pH and increased H2 concentrations in breath compared
with those who consumed the control diet. Interestingly, in exper-
iment 3 (Table 2) we observed that the acetate concentration in the
portal vein was positively correlated with that in arterial blood
(r 0·62) and Ra of acetate (r 0·56) and inversely correlated with
acetate isotope enrichment in arterial blood (r 20·62). Non-
labelled acetate, probably originating from the caecum, diluted
the tracer and lowered the isotope enrichment after the chicory
compared with the control diet. The Ra of acetate was also corre-
lated with the acetate concentration in the caecum (r 0·63). The
estimated release of acetate from the intestine (Table 3) was cor-
related with the Ra and with the concentration of acetate in the
Table 2. Concentrations, isotope enrichments and rates of appearance of plasma acetate, propionate and butyrate in arterial and portal vein blood in
rats submitted to 4-week chicory or control diets (Expt 3)
(Mean values with their standard errors)
Concentrations (mmol/l) Isotope enrichments (MPE) Rate of appearance (mmol/kg per min)
Diet group. . . Control (n 8) Chicory (n 10) Control (n 8) Chicory (n 10) Control (n 8) Chicory (n 10)
Mean SEM Mean SEM Mean SEM Mean SEM Mean SEM Mean SEM
Acetate
Artery 287 22 352* 22 13·0 0·9 10·6* 0·7 19·7 1·6 24·7* 1·5
Portal vein 756 105 953 79 2·4 0·7 1·5 0·3 – – – –
Propionate
Artery 20 3 21 3 22·7 2·8 22·6 2·3 3·8 0·6 3·7 0·5
Portal vein 148 37 172 31 2·0 0·6 1·8 0·2 – – – –
Butyrate
Artery 9 2 9 1 28·8 3·6 26·5 3·4 1·3 0·2 1·6 0·3
Portal vein 237 72 238 58 1·6 0·6 0·6* 0·2 – – – –
MPE, mole percent excess.
* Mean value was significantly different from that of the control group (P,0·05).
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peripheral circulation (r 0·50 and 0·58, respectively; Table 2). No
such correlations could be observed for propionate or butyrate.
However, a lower isotope enrichment of butyrate in the portal
vein after chicory (Table 2) suggests that some non-labelled buty-
rate escapes mucosal uptake after its production in the intestine.
A lower concentration of butyrate was observed in the colon
after the chicory than after the control diet and was possibly due
to a more efficient transport of SCFA through the gut barrier
during fermentation.
In the present study we showed that acetate turnover
increased by 25 % in peripheral blood circulation, while pro-
pionate and butyrate turnover rates were unchanged in chic-
ory-treated rats. In a previous study, dogs adapted to 3-week
chicory intake showed a similar 31 % increase in acetate turn-
over26. In a previous clinical trial27, healthy adults that were
submitted to an acute lactulose oral intake showed a sharp
63 % increase in acetate turnover rate. No comparisons are
available for propionate and butyrate turnovers to our knowl-
edge. The present approach provides information about the net
contribution of intestinal fermentation to peripheral metab-
olism, in terms of carbon flux available for either energy or
for anabolic processes. Previous approaches using arterio–
venous differences combined with a measure of blood flow
provide similar information, however, with less accuracy.
The latter, and tracer methods, have been thoroughly studied
in ruminants28,29. Measurements of SCFA concentrations in
the intestinal lumen or portal vein only provide static infor-
mation about the production and absorption of SCFA at a par-
ticular moment in time30, and neglect the dynamic nature and
physiological meaning of SCFA production rates. The present
approach could have been improved by catheterising the portal
vein to assess true SCFA production rates from the intestine in
rats. Nevertheless, the present approach could be used in clini-
cal research to measure SCFA turnover rates. SCFA turnover
rates may differ in man and we cannot exclude, unlike acetate,
that peripheral propionate and butyrate turnover rates can be
beneficially modulated by consuming dietary fibres.
From the present, and previous studies, we have attempted
to describe SCFA metabolism (Fig. 1). After absorption
through the intestinal endothelial cells, SCFA are activated
by enzyme acyl-CoA synthetase to serve as fuel for cellular
energy or as an intermediate for intestine metabolism24,31 – 33.
Following absorption, butyrate is activated to produce butyryl-
CoA. Butyrate is mainly metabolised in the colonocytes and is
known to serve as a fuel for intestinal cells34. Acetate and pro-
pionate are absorbed and partially escape the filtering capacity
of the intestine. Intestinal acetate release increased 30 % into
the portal vein, propionate release increased, but not signifi-
cantly, while intestinal butyrate release did not increase after
chicory ingestion in the present study. Independent of the
diet, the liver retains most of the portal propionate and buty-
rate35, where propionyl-CoA and butyryl-CoA are probably
involved in gluconeogenesis and lipogenesis in hepato-
cytes36,37. The non-negligible concentrations and turnover
rates of propionate and butyrate were unchanged and constant
in the post-hepatic circulation; these originate either from an
endogenous production or from discrete amount of SCFA
escaping the splanchnic filter. To a lesser proportion, acetate
was retained and probably metabolised by the liver35,38. Con-
sidering that approximately 0·2 g inulin/h were reaching the rat
hindgut, during the last trial, and taking into account the stoi-
chiometric macrobiota degradation of inulin into SCFA
after Roberfroid et al.39, it is possible to theoretically estimate
that approximately 50mmol acetate/kg per min was produced
in the gut. By comparing the chicory and control diet
groups, the difference in acetate turnovers assessed in the
peripheral circulation was about 5mmol/kg per min; that is,
only 10 % of the theoretical caeco-colonic production.
This suggests that a large amount of acetate is taken up and
used by the splanchnic tissues in rats. The role(s) of such
Fig. 4. Time-course of isotope enrichments of (A) [1,2-13C2]acetate, (B)
[1-13C]propionate and (C) [1-13C]butyrate in arterial plasma during simul-
taneous IV infusions of labelled acetate, propionate and butyrate in rats pre-
viously submitted to a 4-week chicory diet (W) or a 4-week control diet (X)
(Expt 3). Data are mean values, with their standard errors represented by
vertical bars.
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low-molecular-weight SCFA metabolites is still not fully
understood. More investigations using stable isotopes would
contribute to the understanding of the function of acetate, pro-
pionate and butyrate in whole-body energy metabolism.
In the present study, simultaneous IV infusions of labelled
acetate, propionate and butyrate were used to determine the
concurrent SCFA turnover rates in the peripheral circulation
of rats. As much as 590mmol acetate/h was turned over in per-
ipheral blood circulation, with turnover rates of 115 and
40mmol/h for propionate and butyrate in food-deprived rats,
respectively. Propionate and butyrate turnover rates appeared
to be non-negligible and their role in systemic metabolism
remains to be elucidated. The intestine and the liver probably
play a role in the peripheral homeostasis of propionate and
butyrate independently of non-digestible carbohydrate fermen-
tation in the gut. Rats consuming a chicory diet for 4 weeks
significantly increased peripheral acetate turnover but turnover
rates of propionate and butyrate did not change when com-
pared with rats on a control diet. Acetate constitutes an
ideal marker of intestinal fermentation in rats. The present quantitative determination of SCFA turnover rates after diet-
ary fibre ingestion is applicable in human subjects and remains
to be investigated.
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